| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 3.72e-08 | 11 | 195 | 5 | GO:0005247 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 4.75e-07 | 17 | 195 | 5 | GO:0008308 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | ITGAV RYR1 CLCN2 CLCN3 CLCN7 CLCNKA CLCNKB KCNJ3 HCN3 ABCC9 RIMBP2 | 1.82e-06 | 182 | 195 | 11 | GO:0005244 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | ITGAV RYR1 CLCN2 CLCN3 CLCN7 CLCNKA CLCNKB KCNJ3 HCN3 ABCC9 RIMBP2 | 2.02e-06 | 184 | 195 | 11 | GO:0022832 |
| GeneOntologyMolecularFunction | extracellular matrix binding | 7.19e-06 | 73 | 195 | 7 | GO:0050840 | |
| GeneOntologyMolecularFunction | denatured protein binding | 2.83e-04 | 3 | 195 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | type II activin receptor binding | 2.83e-04 | 3 | 195 | 2 | GO:0070699 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.84e-04 | 171 | 195 | 8 | GO:0015103 | |
| GeneOntologyMolecularFunction | laminin binding | 3.25e-04 | 34 | 195 | 4 | GO:0043236 | |
| GeneOntologyMolecularFunction | gated channel activity | ITGAV RYR1 CLCN2 CLCN3 CLCN7 CLCNKA CLCNKB KCNJ3 HCN3 ABCC9 RIMBP2 | 4.62e-04 | 334 | 195 | 11 | GO:0022836 |
| GeneOntologyMolecularFunction | neurexin family protein binding | 4.68e-04 | 16 | 195 | 3 | GO:0042043 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 6.11e-04 | 70 | 195 | 5 | GO:0008235 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 6.72e-04 | 18 | 195 | 3 | GO:0051787 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, phosphate group as acceptor | 6.73e-04 | 41 | 195 | 4 | GO:0016776 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 7.38e-04 | 42 | 195 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 8.01e-04 | 200 | 195 | 8 | GO:0008237 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 9.31e-04 | 5 | 195 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound kinase activity | 1.13e-03 | 47 | 195 | 4 | GO:0019205 | |
| GeneOntologyMolecularFunction | sulfur compound binding | ACADVL ITGA2 PTPRS DMBT1 APOB ADAMTS8 ADAMTS5 PPIA HADHA AGRN | 1.33e-03 | 323 | 195 | 10 | GO:1901681 |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.39e-03 | 6 | 195 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 1.39e-03 | 6 | 195 | 2 | GO:0055131 | |
| GeneOntologyMolecularFunction | nucleoside monophosphate kinase activity | 1.41e-03 | 23 | 195 | 3 | GO:0050145 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.44e-03 | 125 | 195 | 6 | GO:0015108 | |
| GeneOntologyMolecularFunction | virus receptor activity | 1.47e-03 | 85 | 195 | 5 | GO:0001618 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 1.50e-03 | 126 | 195 | 6 | GO:0051082 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 1.55e-03 | 86 | 195 | 5 | GO:0140272 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.55e-03 | 86 | 195 | 5 | GO:0005254 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 2.38e-06 | 11 | 194 | 4 | GO:0097104 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 1.41e-05 | 56 | 194 | 6 | GO:0001941 | |
| GeneOntologyBiologicalProcess | membrane organization | EPHB2 CPLANE2 TRMT10B ITGA2 EPB41L3 FER1L6 MAGI2 CLCN2 CLCN3 DLG2 NLGN2 PLEC HSPA1A MTCH2 FCHSD1 NLGN1 CR1 SLC4A1 RIMBP2 RIMS1 AGRN MUSK CHP1 | 1.74e-05 | 914 | 194 | 23 | GO:0061024 |
| GeneOntologyBiologicalProcess | regulation of viral genome replication | 2.43e-05 | 91 | 194 | 7 | GO:0045069 | |
| GeneOntologyBiologicalProcess | cell junction assembly | EPHB2 HIPK1 MDGA2 ITGA2 EPB41L3 ITGAV MAGI2 LRFN4 PTPRS TESK2 EEF2K NLGN2 PLEC NLGN1 PARD3 AGRN MUSK | 2.86e-05 | 569 | 194 | 17 | GO:0034329 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle clustering | 4.43e-05 | 8 | 194 | 3 | GO:2000809 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 4.48e-05 | 42 | 194 | 5 | GO:0099560 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | EPHB2 CYLD TCAF1 SYNJ2BP NLGN2 RNF31 NLGN1 PPIA TESK1 PPID ZIC1 PRKAR1A IRS2 EDEM1 AGRN MUSK CHP1 | 4.60e-05 | 591 | 194 | 17 | GO:1903829 |
| GeneOntologyBiologicalProcess | positive regulation of protein geranylgeranylation | 8.80e-05 | 2 | 194 | 2 | GO:2000541 | |
| GeneOntologyBiologicalProcess | regulation of protein geranylgeranylation | 8.80e-05 | 2 | 194 | 2 | GO:2000539 | |
| GeneOntologyBiologicalProcess | transepithelial chloride transport | 9.36e-05 | 10 | 194 | 3 | GO:0030321 | |
| GeneOntologyBiologicalProcess | viral life cycle | ITGA2 ITGAV STAU1 SETDB1 HSPA1A HSPA1B CR1 PPIA PPID PDE12 EIF2AK2 ZC3HAV1 | 9.55e-05 | 340 | 194 | 12 | GO:0019058 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.03e-04 | 153 | 194 | 8 | GO:0098656 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 1.30e-04 | 202 | 194 | 9 | GO:0051963 | |
| GeneOntologyBiologicalProcess | receptor clustering | 1.33e-04 | 83 | 194 | 6 | GO:0043113 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | EPHB2 CYLD ARHGAP24 MDGA2 SETDB1 LRFN4 PTPRS EEF2K NLGN2 HSPA1A HSPA1B FCHSD1 FLII NUDT16 STXBP5 ARHGEF18 NLGN1 TESK1 SH3PXD2B RHPN2 RHPN2P1 RIMS1 EIF2AK2 AGRN MUSK | 1.38e-04 | 1189 | 194 | 25 | GO:0044087 |
| GeneOntologyBiologicalProcess | positive regulation of synapse assembly | 1.61e-04 | 86 | 194 | 6 | GO:0051965 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle clustering | 1.69e-04 | 12 | 194 | 3 | GO:2000807 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | EPHB2 CYLD MAGI1 MYF5 HLA-DOA DISC1 DACT2 MDGA2 ITGA2 ITGAV IL1RL2 MAGI2 PLXNA1 PRKD2 SIPA1 CR1 TESK1 SLC4A1 CCM2L PRKAR1A IL6ST | 1.81e-04 | 927 | 194 | 21 | GO:0030155 |
| GeneOntologyBiologicalProcess | postsynapse organization | EPHB2 DISC1 MAGI2 LRFN4 PTPRS DLG2 EEF2K NLGN2 NLGN1 AGRN MUSK | 1.94e-04 | 313 | 194 | 11 | GO:0099173 |
| GeneOntologyBiologicalProcess | positive regulation of viral genome replication | 1.96e-04 | 31 | 194 | 4 | GO:0045070 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CPLANE2 CYLD MAGI1 HLA-DOA MDGA2 ITGA2 KIRREL2 ITGAV IL1RL2 MAGI2 LRFN4 PTPRS PDIA2 DLG2 NLGN2 NLGN1 CR1 PPIA SLC4A1 CCM2L PRKAR1A PARD3 IL6ST | 2.08e-04 | 1077 | 194 | 23 | GO:0098609 |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 2.14e-04 | 58 | 194 | 5 | GO:0097106 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine development | 2.20e-04 | 91 | 194 | 6 | GO:0060998 | |
| GeneOntologyBiologicalProcess | protein targeting | TCAF1 TRMT10B SYNJ2BP VPS13C MIPEP VPS13A MTCH2 RNF31 NLGN1 EDEM1 PARD3 CHP1 | 2.26e-04 | 373 | 194 | 12 | GO:0006605 |
| GeneOntologyBiologicalProcess | postsynapse assembly | 2.48e-04 | 93 | 194 | 6 | GO:0099068 | |
| GeneOntologyBiologicalProcess | presynapse assembly | 2.51e-04 | 60 | 194 | 5 | GO:0099054 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic assembly at neuromuscular junction | 2.62e-04 | 3 | 194 | 2 | GO:0045887 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 2.82e-04 | 34 | 194 | 4 | GO:0097107 | |
| GeneOntologyBiologicalProcess | viral genome replication | 3.21e-04 | 137 | 194 | 7 | GO:0019079 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 3.49e-04 | 183 | 194 | 8 | GO:0006820 | |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB2 HIPK1 DISC1 MDGA2 ITGA2 EPB41L3 ITGAV STAU1 MAGI2 LRFN4 PTPRS TESK2 DLG2 EEF2K NLGN2 PLEC LNX1 NLGN1 PARD3 AGRN MUSK | 3.51e-04 | 974 | 194 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | EPB41L3 PLEC FLII ARHGEF18 TESK1 SH3PXD2B RHPN2 RHPN2P1 PRKAR1A | 4.50e-04 | 239 | 194 | 9 | GO:0031032 |
| GeneOntologyCellularComponent | glutamatergic synapse | EPHB2 DISC1 MDGA2 STAU1 MAGI2 LRFN4 CLCN3 PTPRS DLG2 EEF2K SIPA1L2 ELMOD1 PLXNA1 SH3GL3 PORCN NLGN1 PRKAR1A RIMBP2 RIMS1 AGRN | 8.93e-05 | 817 | 196 | 20 | GO:0098978 |
| GeneOntologyCellularComponent | anchoring junction | MAGI1 ARHGAP24 ITGA2 KIRREL2 EPB41L3 ITGAV MAGI2 DLG2 PLEC DNMBP HSPA1A HSPA1B FLII HYOU1 MAGI3 PPIA SLC4A1 SH3PXD2B PARD3 SNTB2 PDZD2 CHP1 | 1.30e-04 | 976 | 196 | 22 | GO:0070161 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.62e-04 | 164 | 196 | 8 | GO:0098982 | |
| GeneOntologyCellularComponent | inhibitory synapse | 1.93e-04 | 31 | 196 | 4 | GO:0060077 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | EPHB2 DISC1 EPB41L3 MAGI2 LRFN4 PTPRS DLG2 EEF2K NLGN2 LNX1 STXBP5 SH3GL3 NLGN1 RIMS1 | 4.38e-04 | 523 | 196 | 14 | GO:0098984 |
| GeneOntologyCellularComponent | neuromuscular junction | 6.61e-04 | 112 | 196 | 6 | GO:0031594 | |
| MousePheno | abnormal blood pH regulation | 9.37e-06 | 13 | 154 | 4 | MP:0003027 | |
| MousePheno | abnormal chloride level | ERMP1 CLVS1 CLCN2 CLCN7 CLCNKA CLCNKB ELMOD1 SLC4A1 CDCA5 MMUT | 2.26e-05 | 174 | 154 | 10 | MP:0012007 |
| MousePheno | acidemia | 4.44e-05 | 7 | 154 | 3 | MP:0003030 | |
| Domain | PDZ | MAGI1 SYNJ2BP MAGI2 DLG2 SIPA1L2 LNX1 MAGI3 SIPA1 PREX2 RHPN2 RIMS1 PARD3 SNTB2 PDZD2 | 4.96e-10 | 148 | 195 | 14 | SM00228 |
| Domain | - | MAGI1 SYNJ2BP MAGI2 DLG2 SIPA1L2 LNX1 MAGI3 SIPA1 PREX2 RHPN2 RIMS1 PARD3 SNTB2 PDZD2 | 5.92e-10 | 150 | 195 | 14 | 2.30.42.10 |
| Domain | PDZ | MAGI1 SYNJ2BP MAGI2 DLG2 SIPA1L2 LNX1 MAGI3 SIPA1 PREX2 RHPN2 RIMS1 PARD3 SNTB2 PDZD2 | 6.47e-10 | 151 | 195 | 14 | PS50106 |
| Domain | PDZ | MAGI1 SYNJ2BP MAGI2 DLG2 SIPA1L2 LNX1 MAGI3 SIPA1 PREX2 RHPN2 RIMS1 PARD3 SNTB2 PDZD2 | 7.06e-10 | 152 | 195 | 14 | IPR001478 |
| Domain | PDZ | MAGI1 SYNJ2BP MAGI2 DLG2 SIPA1L2 LNX1 MAGI3 SIPA1 PREX2 RIMS1 PARD3 SNTB2 PDZD2 | 2.88e-09 | 141 | 195 | 13 | PF00595 |
| Domain | Cl-channel_core | 1.44e-08 | 9 | 195 | 5 | IPR014743 | |
| Domain | - | 1.44e-08 | 9 | 195 | 5 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 1.44e-08 | 9 | 195 | 5 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.44e-08 | 9 | 195 | 5 | IPR001807 | |
| Domain | CBS | 4.69e-07 | 16 | 195 | 5 | SM00116 | |
| Domain | CBS_dom | 1.61e-06 | 20 | 195 | 5 | IPR000644 | |
| Domain | CBS | 1.61e-06 | 20 | 195 | 5 | PF00571 | |
| Domain | CBS | 1.61e-06 | 20 | 195 | 5 | PS51371 | |
| Domain | Guanylate_kinase_CS | 1.90e-05 | 16 | 195 | 4 | IPR020590 | |
| Domain | GUANYLATE_KINASE_2 | 8.73e-05 | 23 | 195 | 4 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 8.73e-05 | 23 | 195 | 4 | PS00856 | |
| Domain | Cl_channel-K | 1.08e-04 | 2 | 195 | 2 | IPR002250 | |
| Domain | Guanylate_kin | 1.44e-04 | 26 | 195 | 4 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 1.44e-04 | 26 | 195 | 4 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 1.44e-04 | 26 | 195 | 4 | IPR008144 | |
| Domain | GuKc | 1.44e-04 | 26 | 195 | 4 | SM00072 | |
| Domain | SH3_2 | 2.82e-04 | 86 | 195 | 6 | PF07653 | |
| Domain | SH3_2 | 2.82e-04 | 86 | 195 | 6 | IPR011511 | |
| Domain | VPS13 | 3.23e-04 | 3 | 195 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 3.23e-04 | 3 | 195 | 2 | PF16910 | |
| Domain | VPS13 | 3.23e-04 | 3 | 195 | 2 | PF16908 | |
| Domain | VPS13_N2 | 3.23e-04 | 3 | 195 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 3.23e-04 | 3 | 195 | 2 | IPR031642 | |
| Domain | HSP70 | 5.68e-04 | 16 | 195 | 3 | PF00012 | |
| Domain | SHR-BD | 6.42e-04 | 4 | 195 | 2 | IPR009543 | |
| Domain | VPS13_C | 6.42e-04 | 4 | 195 | 2 | PF16909 | |
| Domain | VPS13_C | 6.42e-04 | 4 | 195 | 2 | IPR031645 | |
| Domain | SHR-BD | 6.42e-04 | 4 | 195 | 2 | PF06650 | |
| Domain | HSP70_2 | 6.84e-04 | 17 | 195 | 3 | PS00329 | |
| Domain | HSP70_1 | 6.84e-04 | 17 | 195 | 3 | PS00297 | |
| Domain | HSP70_3 | 6.84e-04 | 17 | 195 | 3 | PS01036 | |
| Domain | Hsp_70_fam | 8.15e-04 | 18 | 195 | 3 | IPR013126 | |
| Domain | DSRM | 9.60e-04 | 19 | 195 | 3 | SM00358 | |
| Domain | Autophagy-rel_C | 1.06e-03 | 5 | 195 | 2 | IPR015412 | |
| Domain | ATG_C | 1.06e-03 | 5 | 195 | 2 | PF09333 | |
| Domain | Nlgn | 1.06e-03 | 5 | 195 | 2 | IPR000460 | |
| Domain | dsrm | 1.12e-03 | 20 | 195 | 3 | PF00035 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.73e-05 | 76 | 152 | 7 | M27219 | |
| Pubmed | CYLD MAGI1 TCAF1 ARHGAP24 EPB41L3 MYEF2 MAGI2 PTPRS PPP1R3F DLG2 NLGN2 NOP2 RASAL2 FLII HCN3 ARHGEF18 SIPA1 PPIA SH3PXD2B N4BP2 PRKAR1A CCAR2 RIMBP2 RIMS1 PARD3 AGRN | 6.38e-11 | 963 | 199 | 26 | 28671696 | |
| Pubmed | Changing expression of chloride channels during preimplantation mouse development. | 7.21e-10 | 9 | 199 | 5 | 23115349 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SERBP1 VPS13C PSMA7 SSRP1 EPB41L3 STAU1 SCAF1 HSPA1A NOP2 MTCH2 PLXNA1 RASAL2 PRKD2 FLII HYOU1 APOB HEATR1 CPOX PPIA TESK1 PDE12 SBNO1 PRKAR1A CCAR2 HADHA UBE3C PSPC1 GFM1 EIF2AK2 ZC3HAV1 | 7.69e-10 | 1425 | 199 | 30 | 30948266 |
| Pubmed | 1.06e-09 | 35 | 199 | 7 | 33864728 | ||
| Pubmed | CYLD ACADVL PSMA7 SSRP1 EPB41L3 STAU1 UBXN4 CLCN7 VPS13A NLE1 EEF2K ITM2C SIPA1L2 HSPA1A NOP2 HSPA1B RASAL2 FRAS1 HYOU1 HEATR1 NBAS PDE12 SLC4A1AP N4BP2 PANK4 PRKAR1A HADHA PARD3 SNTB2 ZC3HAV1 | 2.07e-09 | 1487 | 199 | 30 | 33957083 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRMT11 IRS1 LYST RYR1 SCAF1 CLCN7 SH3TC1 PTPRS NLE1 NLGN2 PLEC SIPA1L2 DNMBP PLXNA1 PRKD2 FLII FRAS1 FBRS TESK1 SH3PXD2B SLC2A4RG XXYLT1 IRS2 UBE3C AGRN | 5.57e-09 | 1105 | 199 | 25 | 35748872 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ACADVL VPS13C PSMA7 TRMT11 SSRP1 STAU1 UBXN4 MIPEP VPS13A RMND1 NOP2 MTCH2 FLII HYOU1 HEATR1 CPOX NBAS PDE12 CLYBL PANK4 CCAR2 HADHA UBE3C PSPC1 GFM1 EIF2AK2 MMUT CHP1 ZC3HAV1 | 9.57e-09 | 1496 | 199 | 29 | 32877691 |
| Pubmed | 1.67e-08 | 15 | 199 | 5 | 23782696 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CYLD MAGI1 IRS1 SSRP1 EPB41L3 LYST TESK2 PLEC SIPA1L2 DNMBP RASAL2 NELFB MAGI3 TESK1 SH3PXD2B N4BP2 IRS2 MAPK4 PARD3 MUSK ZC3HAV1 | 2.86e-08 | 861 | 199 | 21 | 36931259 |
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 5.49e-08 | 36 | 199 | 6 | 26053890 | |
| Pubmed | ACADVL PSMA7 DACT2 SSRP1 EPB41L3 LYST FER1L6 UBXN4 PXDN CLCN3 VPS13A PDIA2 NLE1 DLG2 PLEC SIPA1L2 HYOU1 MAGI3 APOB HEATR1 CPOX SBNO1 N4BP2 CCAR2 HADHA RIMS1 PSPC1 | 6.62e-08 | 1442 | 199 | 27 | 35575683 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | SERBP1 ACADVL RHBDD2 IRS1 EPB41L3 ITGAV MAGI2 UBXN4 ITM2C PLEC MTCH2 PLXNA1 SLC27A3 HYOU1 ADAMTS5 CPOX CR1 PPIA PDE12 SLC4A1AP XXYLT1 HADHA PSPC1 GFM1 AGRN CHP1 ZC3HAV1 | 7.51e-08 | 1451 | 199 | 27 | 30550785 |
| Pubmed | HIPK1 EPB41L3 MAGI2 DLG2 ITM2C NLGN2 PLEC SIPA1L2 STXBP5 HCN3 RIMBP2 RIMS1 SNTB2 | 1.21e-07 | 347 | 199 | 13 | 17114649 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 20685959 | ||
| Pubmed | SERBP1 DDAH1 PSMA7 ITGA2 EPB41L3 MYEF2 STAU1 MAGI2 PTPRS DLG2 ITM2C PLEC SIPA1L2 HSPA1A HSPA1B MTCH2 RASAL2 FLII HYOU1 SIPA1 SLC4A1 PRKAR1A RIMBP2 HADHA RIMS1 PSPC1 | 2.12e-07 | 1431 | 199 | 26 | 37142655 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | SERBP1 VPS13C ERMP1 SSRP1 STAU1 PLEC HSPA1B FLII PPIA EIF2AK2 ZC3HAV1 | 4.74e-07 | 268 | 199 | 11 | 33024031 |
| Pubmed | 5.32e-07 | 52 | 199 | 6 | 23182705 | ||
| Pubmed | CYLD HIPK1 MAGI2 SETDB1 PXDN SIPA1L2 FRAS1 STXBP5 NLGN1 CCAR2 RIMBP2 UBE3C PDZD2 | 7.40e-07 | 407 | 199 | 13 | 12693553 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 1.16e-06 | 182 | 199 | 9 | 31067453 | |
| Pubmed | Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation. | 1.42e-06 | 34 | 199 | 5 | 30726710 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.48e-06 | 139 | 199 | 8 | 16985003 | |
| Pubmed | Interaction between autism-linked MDGAs and neuroligins suppresses inhibitory synapse development. | 1.83e-06 | 5 | 199 | 3 | 23358245 | |
| Pubmed | 1.85e-06 | 64 | 199 | 6 | 22261194 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TCAF1 SERBP1 ACADVL PSMA7 SSRP1 FBXO22 PLEC HSPA1A NOP2 MTCH2 FLII HYOU1 AIMP2 NELFB PPIA SBNO1 SLC4A1AP CCAR2 IRS2 HADHA PSPC1 EIF2AK2 CHP1 ZC3HAV1 | 2.15e-06 | 1415 | 199 | 24 | 28515276 |
| Pubmed | CYLD SERBP1 MORN4 ACADVL EPB41L3 MYEF2 STAU1 MAGI2 UBXN4 KCNJ3 DLG2 ITM2C PLEC SIPA1L2 HSPA1B FLII PPIA PRKAR1A HADHA RIMS1 GFM1 | 2.72e-06 | 1139 | 199 | 21 | 36417873 | |
| Pubmed | 3.61e-06 | 209 | 199 | 9 | 26389662 | ||
| Pubmed | 3.64e-06 | 6 | 199 | 3 | 15509766 | ||
| Pubmed | SERBP1 DISC1 EPB41L3 STAU1 PLEC HSPA1A NOP2 SLC4A1AP N4BP2 PRKAR1A CCAR2 PSPC1 EIF2AK2 ZC3HAV1 | 4.03e-06 | 551 | 199 | 14 | 34728620 | |
| Pubmed | 5.08e-06 | 164 | 199 | 8 | 32409323 | ||
| Pubmed | 6.35e-06 | 7 | 199 | 3 | 24025447 | ||
| Pubmed | VPS13C RHBDD2 ITGAV LYST UBXN4 CLCN7 VPS13A PLXNA1 RASAL2 STXBP5 NBAS CHP1 ZC3HAV1 | 7.64e-06 | 504 | 199 | 13 | 34432599 | |
| Pubmed | SERBP1 VPS13C DACT2 SSRP1 LRFN4 SHPRH DMBT1 HSPA1A NOP2 MTCH2 FLII APOB HEATR1 PPIA PSPC1 SNTB2 | 8.03e-06 | 754 | 199 | 16 | 35906200 | |
| Pubmed | 8.46e-06 | 23 | 199 | 4 | 29728617 | ||
| Pubmed | 1.00e-05 | 50 | 199 | 5 | 23658023 | ||
| Pubmed | Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice. | 1.01e-05 | 8 | 199 | 3 | 12766770 | |
| Pubmed | Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. | 1.01e-05 | 8 | 199 | 3 | 22495301 | |
| Pubmed | Proteomic analysis of beta1-adrenergic receptor interactions with PDZ scaffold proteins. | 1.01e-05 | 8 | 199 | 3 | 16316992 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | ZBTB17 SETDB1 TESK2 LNX1 PRKD2 TESK1 KLHL15 MAPK4 EIF2AK2 HERC4 MUSK | 1.11e-05 | 372 | 199 | 11 | 22939624 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PSMA7 SSRP1 EPB41L3 MYEF2 STAU1 FBXO22 NLE1 PLEC NOP2 RASAL2 FLII AIMP2 RNF31 HEATR1 PPIA PDE12 CCAR2 HADHA PARD3 EIF2AK2 AGRN ZC3HAV1 | 1.14e-05 | 1353 | 199 | 22 | 29467282 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | EPHB2 RHBDD2 ERMP1 MYEF2 LRFN4 CLCN7 PTPRS MIPEP VPS13A ITM2C RMND1 HSPA1A PLXNA1 APOB XXYLT1 CCAR2 UBE3C GFM1 IL6ST | 1.25e-05 | 1061 | 199 | 19 | 33845483 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | EPB41L3 ITGAV CLCN7 PTPRS DLG2 ITM2C RASAL2 STXBP5 IL6ST SNTB2 ZC3HAV1 | 1.25e-05 | 377 | 199 | 11 | 38117590 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPHB2 TCAF1 PSMA7 SSRP1 EPB41L3 STAU1 SETDB1 UBXN4 HSPA1A NOP2 MTCH2 HYOU1 CALML3 MUC5B CPOX PPID SH3PXD2B PDE12 HADHA PSPC1 MMUT ZC3HAV1 | 1.33e-05 | 1367 | 199 | 22 | 32687490 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FBXO22 PTPRS RMND1 SIPA1L2 NOP2 MTCH2 SLC27A3 PRKD2 HYOU1 HEATR1 CPOX CCAR2 IRS2 UBE3C EDEM1 GFM1 SNTB2 ZC3HAV1 | 1.41e-05 | 974 | 199 | 18 | 28675297 |
| Pubmed | 1.51e-05 | 9 | 199 | 3 | 9278515 | ||
| Pubmed | 1.65e-05 | 27 | 199 | 4 | 35377412 | ||
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | IP6K1 ITGA2 ITGAV UBXN4 CLCN7 VPS13A MTCH2 HYOU1 RNF31 NBAS CHP1 ZC3HAV1 | 1.82e-05 | 468 | 199 | 12 | 31056421 |
| Pubmed | IRS1 RRAD SSRP1 STAU1 CLCN7 NOP2 COL1A2 HYOU1 MUC5B SIPA1 HADHA UBE3C CHP1 ZC3HAV1 | 1.94e-05 | 634 | 199 | 14 | 34591612 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB2 MANBA ERMP1 ITGA2 ITGAV FBXO22 PXDN PTPRS ITM2C MTCH2 PLXNA1 SLC27A3 FRAS1 HYOU1 XXYLT1 EDEM1 EIF2AK2 AGRN IL6ST CHP1 | 2.08e-05 | 1201 | 199 | 20 | 35696571 |
| Pubmed | Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma. | 2.15e-05 | 10 | 199 | 3 | 19124510 | |
| Pubmed | ACADVL SSRP1 STAU1 NLE1 FLII HEATR1 PRKAR1A PSPC1 EIF2AK2 ZC3HAV1 | 2.39e-05 | 332 | 199 | 10 | 25693804 | |
| Pubmed | CYLD SSRP1 EPB41L3 MYEF2 SCAF1 SETDB1 CLCNKA SH3TC1 ITM2C SIPA1L2 PRKD2 GINS3 RNF31 FBRS SIPA1 SLC4A1 PANK4 IRS2 PARD3 | 2.50e-05 | 1116 | 199 | 19 | 31753913 | |
| Pubmed | SERBP1 VPS13C RHBDD2 EPB41L3 UBXN4 CLCN7 VPS13A HSPA1A STXBP5 NBAS SH3PXD2B CHP1 ZC3HAV1 | 2.68e-05 | 568 | 199 | 13 | 37774976 | |
| Pubmed | SERBP1 PSMA7 TRMT11 SSRP1 STAU1 FBXO22 HSPA1A NOP2 FLII GINS3 HYOU1 AIMP2 NELFB CPOX PPIA PRKAR1A CCAR2 HADHA EIF2AK2 SNTB2 ZC3HAV1 | 2.95e-05 | 1335 | 199 | 21 | 29229926 | |
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 3.26e-05 | 2 | 199 | 2 | 12411538 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 2868009 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 17222321 | ||
| Pubmed | Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients. | 3.26e-05 | 2 | 199 | 2 | 24328534 | |
| Pubmed | Kinase- and rapsyn-independent activities of the muscle-specific kinase (MuSK). | 3.26e-05 | 2 | 199 | 2 | 15062984 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 3786141 | ||
| Pubmed | MAGI-1: a widely expressed, alternatively spliced tight junction protein. | 3.26e-05 | 2 | 199 | 2 | 11969287 | |
| Pubmed | The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. | 3.26e-05 | 2 | 199 | 2 | 27335120 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 14678832 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 11934690 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 8812470 | ||
| Pubmed | Roles of Insulin Receptor Substrates (IRS) in renal function and renal hemodynamics. | 3.26e-05 | 2 | 199 | 2 | 33270683 | |
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 3.26e-05 | 2 | 199 | 2 | 26923070 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 25919862 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 16482515 | ||
| Pubmed | Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. | 3.26e-05 | 2 | 199 | 2 | 11864979 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 15975995 | ||
| Pubmed | Systematic modeling for the insulin signaling network mediated by IRS(1) and IRS(2). | 3.26e-05 | 2 | 199 | 2 | 24703981 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 27708333 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 15719414 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 26976620 | ||
| Pubmed | Impairment of bone healing by insulin receptor substrate-1 deficiency. | 3.26e-05 | 2 | 199 | 2 | 14736890 | |
| Pubmed | Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. | 3.26e-05 | 2 | 199 | 2 | 21187371 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 10512679 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 21356519 | ||
| Pubmed | Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. | 3.26e-05 | 2 | 199 | 2 | 20430459 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 22994406 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 20235222 | ||
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 3.26e-05 | 2 | 199 | 2 | 20876613 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 20223214 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 15069074 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 19596788 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 3.26e-05 | 2 | 199 | 2 | 23704948 | |
| Pubmed | Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis. | 3.26e-05 | 2 | 199 | 2 | 19259821 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 12810606 | ||
| Pubmed | Structure and expression of the human gene encoding major heat shock protein HSP70. | 3.26e-05 | 2 | 199 | 2 | 2858050 | |
| Pubmed | Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss. | 3.26e-05 | 2 | 199 | 2 | 38069401 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 11522686 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 34449768 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 17513788 | ||
| Pubmed | IL-6 activates HSP72 gene expression in human skeletal muscle. | 3.26e-05 | 2 | 199 | 2 | 12207910 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 28837204 | ||
| Pubmed | Co-expression of activin receptor-interacting protein 1 and 2 in mouse nerve cells. | 3.26e-05 | 2 | 199 | 2 | 23523645 | |
| Pubmed | Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers. | 3.26e-05 | 2 | 199 | 2 | 29717275 | |
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 29572464 | ||
| Pubmed | 3.26e-05 | 2 | 199 | 2 | 15988927 | ||
| Interaction | GART interactions | ARHGAP24 SERBP1 PSMA7 STAU1 MEX3A HSPA1A PRKD2 AIMP2 PAGE4 SH3GL3 ARHGEF18 CPOX PPIA PRKAR1A | 6.02e-08 | 230 | 196 | 14 | int:GART |
| Interaction | ANK1 interactions | 1.15e-06 | 56 | 196 | 7 | int:ANK1 | |
| Interaction | HSP90AA1 interactions | CYLD ARHGAP24 SERBP1 ZBTB17 IRF3 SETDB1 MEX3A TESK2 LNX1 HSPA1A HSPA1B PRKD2 FLII COL6A3 GINS3 AIMP2 RNF31 PAGE4 APOB TESK1 PPID GSDMD KLHL15 CCAR2 HADHA MAPK4 EDEM1 EIF2AK2 HERC4 CDCA5 MUSK | 1.75e-06 | 1263 | 196 | 31 | int:HSP90AA1 |
| Interaction | CDC37 interactions | EPHB2 CPLANE2 CYLD SERBP1 CYP2C9 DISC1 TESK2 HSPA1A HYOU1 RNF31 CPOX PPIA PPID GSDMD CCAR2 MAPK4 EIF2AK2 CDCA5 AGRN MUSK | 5.20e-06 | 645 | 196 | 20 | int:CDC37 |
| Interaction | RHOA interactions | MAGI1 SERBP1 VPS13C AK9 ITGA2 EPB41L3 ITGAV UBXN4 CLCN7 PTPRS VPS13A HSPA1A ELMOD1 MTCH2 PLXNA1 RASAL2 STXBP5 VASH1 ARHGEF18 HEATR1 SIPA1 PPIA PREX2 RHPN2 PARD3 IL6ST SNTB2 CHP1 ZC3HAV1 | 5.25e-06 | 1199 | 196 | 29 | int:RHOA |
| Interaction | TOP3B interactions | TRMT11 IRS1 SSRP1 LYST RYR1 STAU1 SCAF1 FBXO22 CLCN7 SH3TC1 PTPRS NLE1 NLGN2 PLEC SIPA1L2 DNMBP NOP2 PLXNA1 PRKD2 FLII FRAS1 HYOU1 FBRS APOB TESK1 SH3PXD2B SLC2A4RG XXYLT1 IRS2 HADHA UBE3C AGRN ZC3HAV1 | 5.34e-06 | 1470 | 196 | 33 | int:TOP3B |
| Interaction | AIFM1 interactions | CYLD ARHGAP24 SERBP1 STAU1 SETDB1 UBXN4 MTMR11 PLEC RMND1 HSPA1A HSPA1B PRKD2 AIMP2 CPOX PPIA PANK4 HADHA GFM1 MMUT | 1.31e-05 | 629 | 196 | 19 | int:AIFM1 |
| Interaction | ADGRB1 interactions | 2.44e-05 | 36 | 196 | 5 | int:ADGRB1 | |
| Interaction | YWHAH interactions | CYLD MAGI1 SERBP1 IRS1 ERMP1 SSRP1 EPB41L3 LYST TESK2 PLEC SIPA1L2 DNMBP HSPA1A RASAL2 PRKD2 NELFB MAGI3 SIPA1 TESK1 SH3PXD2B RHPN2 CCAR2 IRS2 RIMS1 PARD3 ZC3HAV1 | 2.60e-05 | 1102 | 196 | 26 | int:YWHAH |
| Interaction | HSPA1B interactions | EPHB2 CYLD ARHGAP24 SERBP1 STAU1 DNMBP HSPA1A HSPA1B SLC27A3 AIMP2 RNF31 MUSK | 4.09e-05 | 301 | 196 | 12 | int:HSPA1B |
| Interaction | SH3PXD2B interactions | 5.20e-05 | 68 | 196 | 6 | int:SH3PXD2B | |
| Interaction | MAT2A interactions | CYLD ARHGAP24 SERBP1 PSMA7 SETDB1 HSPA1A AIMP2 PAGE4 SH3GL3 PRKAR1A | 5.67e-05 | 218 | 196 | 10 | int:MAT2A |
| Interaction | SRR interactions | 6.65e-05 | 23 | 196 | 4 | int:SRR | |
| Interaction | PSMD4 interactions | CYLD SERBP1 CYP2C9 PSMA7 ITGA2 HSPA1A HSPA1B AIMP2 PAGE4 PPIA HADHA UBE3C AGRN | 6.78e-05 | 368 | 196 | 13 | int:PSMD4 |
| Interaction | EEF1A1P5 interactions | 7.29e-05 | 141 | 196 | 8 | int:EEF1A1P5 | |
| Interaction | FMR1 interactions | CYLD MAGI1 ARHGAP24 SERBP1 STAU1 EFHC1 MEX3A DLG2 ARHGEF18 MAGI3 PPIA N4BP2 CCAR2 PARD3 PSPC1 ZC3HAV1 | 7.42e-05 | 536 | 196 | 16 | int:FMR1 |
| Interaction | DNAJC7 interactions | SERBP1 VPS13C DISC1 PSMA7 STAU1 FBXO22 VPS13A HSPA1A HSPA1B MTCH2 HYOU1 AIMP2 PANK4 HERC4 | 7.53e-05 | 425 | 196 | 14 | int:DNAJC7 |
| Interaction | MAP1B interactions | CYLD SERBP1 PSMA7 STAU1 SETDB1 HSPA1A HSPA1B PRKD2 AIMP2 RNF31 PAGE4 PPIA HSPB6 CCAR2 HADHA AGRN | 7.92e-05 | 539 | 196 | 16 | int:MAP1B |
| Interaction | YWHAG interactions | CYLD MAGI1 SERBP1 DISC1 IRS1 EPB41L3 LYST LRFN4 TESK2 SHPRH SIPA1L2 DNMBP LNX1 HSPA1A RASAL2 RNF31 PAGE4 NELFB MAGI3 SIPA1 TESK1 RHPN2 N4BP2 HSPB6 IRS2 PARD3 ZC3HAV1 | 7.96e-05 | 1248 | 196 | 27 | int:YWHAG |
| GeneFamily | PDZ domain containing | MAGI1 SYNJ2BP MAGI2 DLG2 SIPA1L2 LNX1 MAGI3 SIPA1 PREX2 RHPN2 RIMS1 PARD3 SNTB2 PDZD2 | 4.55e-12 | 152 | 130 | 14 | 1220 |
| GeneFamily | Chloride voltage-gated channels | 4.36e-09 | 10 | 130 | 5 | 302 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | RYR1 STAU1 CLCN7 PPP1R3F DLG2 PREX2 HSPB6 RIMBP2 PARD3 EIF2AK2 | 7.45e-07 | 181 | 130 | 10 | 694 |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 3.37e-05 | 26 | 130 | 4 | 904 | |
| GeneFamily | Heat shock 70kDa proteins | 2.29e-04 | 17 | 130 | 3 | 583 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.09e-03 | 161 | 130 | 6 | 593 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN | ACADVL FBXO22 PLEC HSPA1B ALPG PDE12 SBNO1 PRKAR1A UBE3C MUSK | 3.27e-06 | 200 | 199 | 10 | M3833 |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TCAF1 IRS1 MAGI2 SSC5D PTPRS NLGN2 COL1A2 COL6A3 PAGE4 ADAMTS5 RIMS1 | 6.67e-10 | 183 | 198 | 11 | 12daaea821e49bc94a01e2496331e92a80d27339 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | MAGI1 ARHGAP24 DDAH1 KIF12 ITGA2 KCNJ3 FRAS1 NLGN1 RHPN2 PARD3 | 1.77e-08 | 194 | 198 | 10 | 5eaaa81f4b2535f983c424aaef00077089526a5c |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.52e-07 | 185 | 198 | 9 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-07 | 189 | 198 | 9 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.96e-07 | 151 | 198 | 8 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-07 | 164 | 198 | 8 | d847d509bb1791638032ade6755d8164586b5bd5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-06 | 179 | 198 | 8 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-06 | 185 | 198 | 8 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 187 | 198 | 8 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-06 | 188 | 198 | 8 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-06 | 189 | 198 | 8 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-06 | 192 | 198 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.42e-06 | 192 | 198 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.71e-06 | 195 | 198 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-06 | 196 | 198 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 199 | 198 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Transverse-T_cell-Tfh|T_cell / Region, Cell class and subclass | 3.15e-06 | 199 | 198 | 8 | 33ffea12b8228e0b5bd8942531c3b21d24224725 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 3.27e-06 | 200 | 198 | 8 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 3.27e-06 | 200 | 198 | 8 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-06 | 166 | 198 | 7 | 6fe8db8d45177a78605681f22e04fa8d0594f2df | |
| ToppCell | Basal_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 9.66e-06 | 166 | 198 | 7 | aea2ae12e4746149ebc6da063ef694381c098f80 | |
| ToppCell | 390C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-05 | 171 | 198 | 7 | 70963f79711fe6088d6d01b29206b17ab89e5e73 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-5|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.31e-05 | 174 | 198 | 7 | 73e1ad4007d94fca25ed7c6fbe5d205d4e1b8a3b | |
| ToppCell | AT1-AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.41e-05 | 176 | 198 | 7 | f86832cfeff5b3cfffe4455c1b96a1420d48ba1e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 178 | 198 | 7 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.69e-05 | 181 | 198 | 7 | 6873c1138b28c130637d06b64981ad11c262e85f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-05 | 181 | 198 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-05 | 181 | 198 | 7 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 182 | 198 | 7 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-05 | 183 | 198 | 7 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.82e-05 | 183 | 198 | 7 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 183 | 198 | 7 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-05 | 185 | 198 | 7 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-05 | 185 | 198 | 7 | 9878392d79734ab5bb977d7f4f5e2e079b9a5353 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-05 | 185 | 198 | 7 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-05 | 186 | 198 | 7 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-05 | 186 | 198 | 7 | 7c1807fca590cdccf7f5734460bac228d33964ca | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.09e-05 | 187 | 198 | 7 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 188 | 198 | 7 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.16e-05 | 188 | 198 | 7 | bcfc426b60d8e5a23a2360bfb68b32868fec9fbf | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 190 | 198 | 7 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 190 | 198 | 7 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.31e-05 | 190 | 198 | 7 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 190 | 198 | 7 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 190 | 198 | 7 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-05 | 190 | 198 | 7 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 190 | 198 | 7 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 190 | 198 | 7 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-05 | 191 | 198 | 7 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.39e-05 | 191 | 198 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-05 | 192 | 198 | 7 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.47e-05 | 192 | 198 | 7 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.47e-05 | 192 | 198 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 2.56e-05 | 193 | 198 | 7 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.56e-05 | 193 | 198 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.64e-05 | 194 | 198 | 7 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | Fibroblast-B_(Myofibroblast)|World / shred on cell class and cell subclass (v4) | 2.73e-05 | 195 | 198 | 7 | a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365 | |
| ToppCell | droplet-Tongue-TONGUE|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 196 | 198 | 7 | 44a30b1a5f3d8c845e5f3bd17d8102a7449f555b | |
| ToppCell | droplet-Tongue-TONGUE-1m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 196 | 198 | 7 | 9935bdb10789e8cfc922dca526ca3bf8317fe270 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 196 | 198 | 7 | a85f5f1e6acc798e9e02b1a21e0ffe87a323c333 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-05 | 196 | 198 | 7 | 9d7b631f24a19a7dc7a28f28525d4019fc8fcf8a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 196 | 198 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.91e-05 | 197 | 198 | 7 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.91e-05 | 197 | 198 | 7 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.91e-05 | 197 | 198 | 7 | 965d5a3f8c9b12cb8a8d3429702ae29ebd8c6122 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.91e-05 | 197 | 198 | 7 | 3f088eb29197bc575400d6dafd8083e69e4a149f | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.91e-05 | 197 | 198 | 7 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-05 | 198 | 198 | 7 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-05 | 198 | 198 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.11e-05 | 199 | 198 | 7 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.11e-05 | 199 | 198 | 7 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.11e-05 | 199 | 198 | 7 | 60a653100aff31f7f96796ff2ec634798bfb4b0d | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 3.11e-05 | 199 | 198 | 7 | 0d1f2b0d10c1f8ee10c448659b2a22ea0a6a6f0d | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.21e-05 | 200 | 198 | 7 | 8d75ce89393df452defacf2ec9a5bd4b7708afbb | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.21e-05 | 200 | 198 | 7 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.21e-05 | 200 | 198 | 7 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.21e-05 | 200 | 198 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.21e-05 | 200 | 198 | 7 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.21e-05 | 200 | 198 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Mesenchymal|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.21e-05 | 200 | 198 | 7 | e5b7d9622b96bb20c81ac76b4e60e8b44fa9cca1 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.21e-05 | 200 | 198 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.21e-05 | 200 | 198 | 7 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 3.21e-05 | 200 | 198 | 7 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Biopsy_IPF-Epithelial-KRT5-/KRT17+|Biopsy_IPF / Sample group, Lineage and Cell type | 3.21e-05 | 200 | 198 | 7 | 2fc7a3b3aea711ad3d96fd9513f4b40533056d86 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.21e-05 | 200 | 198 | 7 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-05 | 200 | 198 | 7 | 6b48ddde83bc6c941d557844aa214d4d2c8e736d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-05 | 200 | 198 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-05 | 200 | 198 | 7 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.21e-05 | 200 | 198 | 7 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.21e-05 | 200 | 198 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.53e-05 | 144 | 198 | 6 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | E12.5-Hematopoietic-Erythroid-enucleate_erythrocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.48e-05 | 149 | 198 | 6 | fb75c1b91b8a0c8221fbbc350666799727b21120 | |
| ToppCell | E12.5-Hematopoietic-Erythroid|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.48e-05 | 149 | 198 | 6 | 08e7f76b7e4b53ff734d50dbc853ecfdeb4b371b | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 6.83e-05 | 155 | 198 | 6 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.59e-05 | 158 | 198 | 6 | 03281e87780e3bacd089903383c016d03c373bf7 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 8.71e-05 | 162 | 198 | 6 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 168 | 198 | 6 | 2781dd6b369427a94c5059b44b4c8f023f5f2988 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.06e-04 | 168 | 198 | 6 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 169 | 198 | 6 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.10e-04 | 169 | 198 | 6 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| Drug | glibenclamide | CYP2C9 IRS1 CLCN2 CLCN3 CLCN7 CLCNKA CLCNKB KCNJ3 PRKD2 CALML3 ABCC9 APOB CPOX KYAT1 PRKAR1A | 1.38e-06 | 382 | 198 | 15 | CID000003488 |
| Drug | 1-phenylpyrazole | 3.95e-06 | 28 | 198 | 5 | CID000070769 | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A | EPHB2 CPLANE2 CYLD TSNAXIP1 ZBTB17 PDIA2 DMBT1 COL6A3 MUC5B IRS2 | 8.48e-06 | 195 | 198 | 10 | 2875_UP |
| Drug | Molsidomine [25717-80-0]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.01e-05 | 199 | 198 | 10 | 5426_DN | |
| Drug | glutamate | EPHB2 DISC1 RYR1 CLCN2 CLCN3 CLCN7 CLCNKA CLCNKB KCNJ3 DLG2 EEF2K NLGN2 PLEC PRKD2 HYOU1 AIMP2 PORCN KYAT1 SLC4A1 HADHA RIMS1 PSPC1 MMUT | 1.15e-05 | 962 | 198 | 23 | CID000000611 |
| Disease | severe acute respiratory syndrome, COVID-19 | EPHB2 MAGI1 LYST MAGI2 PXDN SIPA1L2 TRMT9B COL6A3 ARHGEF18 PREX2 XXYLT1 RIMBP2 PARD3 EIF2AK2 PDZD2 | 3.10e-07 | 447 | 194 | 15 | EFO_0000694, MONDO_0100096 |
| Disease | Bartter disease type 4B | 4.30e-05 | 2 | 194 | 2 | cv:C4310805 | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 4.30e-05 | 2 | 194 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 4.30e-05 | 2 | 194 | 2 | 613090 | |
| Disease | BARTTER SYNDROME, TYPE 4B | 4.30e-05 | 2 | 194 | 2 | C2751312 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 4.30e-05 | 2 | 194 | 2 | C4310805 | |
| Disease | Bartter disease type 4b (is_implicated_in) | 4.30e-05 | 2 | 194 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 4.30e-05 | 2 | 194 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | Bartter disease (implicated_via_orthology) | 4.30e-05 | 2 | 194 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 4.30e-05 | 2 | 194 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | cortical thickness | MAGI1 DDAH1 STAU1 GLI4 PLEC ZSWIM4 LNX1 MTCH2 ZNF438 TRMT9B FLII ABCC9 ADAMTS8 PPID SH3PXD2B CLYBL PARD3 MUSK ERCC6L2-AS1 PDZD2 | 4.90e-05 | 1113 | 194 | 20 | EFO_0004840 |
| Disease | hair colour measurement | ARHGAP24 ZBTB17 LYST MYEF2 PXDN SIPA1L2 LNX1 PLXNA1 FLII FRAS1 SH3GL3 HADHA PARD3 PADI3 | 6.17e-05 | 615 | 194 | 14 | EFO_0007822 |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 1.28e-04 | 3 | 194 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 1.28e-04 | 3 | 194 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 1.44e-04 | 171 | 194 | 7 | DOID:9352 (is_implicated_in) | |
| Disease | dodecanoylcarnitine measurement | 2.56e-04 | 4 | 194 | 2 | EFO_0021804 | |
| Disease | Juvenile myoclonic epilepsy | 2.56e-04 | 4 | 194 | 2 | cv:C0270853 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 4.24e-04 | 5 | 194 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | Myasthenic Syndromes, Congenital | 5.12e-04 | 24 | 194 | 3 | C0751882 | |
| Disease | vital capacity | TRMT10B AK9 STAU1 MTMR11 LNX1 MTCH2 PLXNA1 COL1A2 ZNF438 COL6A3 APOB ADAMTS8 SLC2A4RG CCAR2 PARD3 MUSK ERCC6L2-AS1 PDZD2 CHP1 | 5.44e-04 | 1236 | 194 | 19 | EFO_0004312 |
| Disease | Bartter syndrome | 6.34e-04 | 6 | 194 | 2 | cv:C0004775 | |
| Disease | Idiopathic generalized epilepsy | 6.34e-04 | 6 | 194 | 2 | cv:C0270850 | |
| Disease | osteoarthritis, knee | 6.42e-04 | 158 | 194 | 6 | EFO_0004616 | |
| Disease | corpus callosum mid-anterior volume measurement | 7.29e-04 | 27 | 194 | 3 | EFO_0010297 | |
| Disease | corpus callosum central volume measurement | 8.12e-04 | 28 | 194 | 3 | EFO_0010296 | |
| Disease | Headache, fasting blood glucose measurement | 8.84e-04 | 7 | 194 | 2 | EFO_0004465, HP_0002315 | |
| Disease | osteopetrosis (implicated_via_orthology) | 8.84e-04 | 7 | 194 | 2 | DOID:13533 (implicated_via_orthology) | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 8.97e-04 | 65 | 194 | 4 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | schizophrenia (implicated_via_orthology) | 1.06e-03 | 68 | 194 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | arteriosclerosis (is_implicated_in) | 1.10e-03 | 31 | 194 | 3 | DOID:2349 (is_implicated_in) | |
| Disease | brain measurement, neuroimaging measurement | MAGI1 DLG2 PLEC ZSWIM4 LNX1 MTCH2 ZNF438 ADAMTS8 RHPN2 SBNO1 PARD3 | 1.10e-03 | 550 | 194 | 11 | EFO_0004346, EFO_0004464 |
| Disease | alkaline phosphatase measurement | CYP2C9 MANBA ACADVL ERMP1 ITM2C NLGN2 DMBT1 PRKD2 APOB CCM2L RHPN2 SLC4A1AP PRKAR1A EDEM1 MUSK ERCC6L2-AS1 | 1.16e-03 | 1015 | 194 | 16 | EFO_0004533 |
| Disease | X-11787 measurement | 1.17e-03 | 8 | 194 | 2 | EFO_0021258 | |
| Disease | familial hyperlipidemia (is_implicated_in) | 1.17e-03 | 8 | 194 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.17e-03 | 8 | 194 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Juvenile Myoclonic Epilepsy | 1.17e-03 | 8 | 194 | 2 | C0270853 | |
| Disease | asthma | CYLD MAGI1 HLA-DOA ERMP1 ITGAV IL1RL2 RNASEH2C PPP1R3F LNX1 COL6A3 SLC2A4RG MUSK ERCC6L2-AS1 | 1.48e-03 | 751 | 194 | 13 | MONDO_0004979 |
| Disease | CCL2 measurement | 1.50e-03 | 126 | 194 | 5 | EFO_0004749 | |
| Disease | tissue plasminogen activator measurement | 1.50e-03 | 9 | 194 | 2 | EFO_0004791 | |
| Disease | amnestic disorder (implicated_via_orthology) | 1.50e-03 | 9 | 194 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.50e-03 | 9 | 194 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Major depression, single episode | 1.50e-03 | 9 | 194 | 2 | C0024517 | |
| Disease | non-small cell lung carcinoma | 1.53e-03 | 75 | 194 | 4 | EFO_0003060 | |
| Disease | Alzheimer disease, polygenic risk score | ARHGAP24 DDAH1 SSRP1 PXDN KCNJ3 DLG2 FRAS1 CR1 SBNO1 HADHA RIMS1 | 1.82e-03 | 586 | 194 | 11 | EFO_0030082, MONDO_0004975 |
| Disease | Combined oxidative phosphorylation deficiency | 1.84e-03 | 37 | 194 | 3 | cv:C4540031 | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 1.87e-03 | 10 | 194 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | cardiovascular system disease (is_marker_for) | 1.87e-03 | 10 | 194 | 2 | DOID:1287 (is_marker_for) | |
| Disease | Nephroblastoma | 1.87e-03 | 10 | 194 | 2 | Orphanet_654 | |
| Disease | sexual dysfunction | 2.27e-03 | 11 | 194 | 2 | EFO_0004714 | |
| Disease | squamous cell lung carcinoma, family history of lung cancer | 2.42e-03 | 85 | 194 | 4 | EFO_0000708, EFO_0006953 | |
| Disease | lobe attachment | 2.55e-03 | 207 | 194 | 6 | EFO_0007667 | |
| Disease | bitter beverage consumption measurement | 2.66e-03 | 42 | 194 | 3 | EFO_0010089 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 2.72e-03 | 12 | 194 | 2 | EFO_0800500 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 3.20e-03 | 13 | 194 | 2 | C0369183 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 3.20e-03 | 13 | 194 | 2 | C1261502 | |
| Disease | bronchopulmonary dysplasia | 3.24e-03 | 45 | 194 | 3 | MONDO_0019091 | |
| Disease | S-warfarin to R-warfarin ratio measurement | 3.62e-03 | 95 | 194 | 4 | EFO_0803331 | |
| Disease | lymphocyte count | CYP2C9 DDAH1 MANBA HLA-DOA LYST ITM2C DMBT1 PLEC HSPA1A HSPA1B PGBD2 MIER2 FRAS1 ARHGEF18 PPID PREX2 SLC4A1 SBNO1 ZC3HAV1 | 3.76e-03 | 1464 | 194 | 19 | EFO_0004587 |
| Disease | myopathy (implicated_via_orthology) | 3.89e-03 | 48 | 194 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | metabolite measurement | 4.12e-03 | 560 | 194 | 10 | EFO_0004725 | |
| Disease | cholesteryl ester 20:3 measurement | 4.13e-03 | 49 | 194 | 3 | EFO_0010347 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 4.13e-03 | 49 | 194 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | amenorrhea, response to antineoplastic agent | 4.27e-03 | 15 | 194 | 2 | EFO_0010269, GO_0097327 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 4.62e-03 | 51 | 194 | 3 | EFO_0022285 | |
| Disease | vision disorder | 4.86e-03 | 16 | 194 | 2 | MONDO_0021084 | |
| Disease | Malaria, susceptibility to | 4.86e-03 | 16 | 194 | 2 | cv:C1970028 | |
| Disease | – | 4.86e-03 | 16 | 194 | 2 | 611162 | |
| Disease | triiodothyronine measurement | 4.86e-03 | 16 | 194 | 2 | EFO_0008392 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 5.48e-03 | 17 | 194 | 2 | C1839839 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 5.48e-03 | 17 | 194 | 2 | C0751883 | |
| Disease | response to radiation, Urinary retention | 5.48e-03 | 17 | 194 | 2 | GO_0009314, HP_0000016 | |
| Disease | Lipidemias | 5.48e-03 | 17 | 194 | 2 | C1706412 | |
| Disease | major depressive disorder (is_implicated_in) | 5.48e-03 | 17 | 194 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | Hyperlipidemia | 5.48e-03 | 17 | 194 | 2 | C0020473 | |
| Disease | Major Depressive Disorder | 5.57e-03 | 243 | 194 | 6 | C1269683 | |
| Disease | eosinophil measurement | 5.70e-03 | 108 | 194 | 4 | EFO_0803540 | |
| Disease | lung adenocarcinoma | 5.98e-03 | 174 | 194 | 5 | EFO_0000571 | |
| Disease | antisaccade response measurement | 6.01e-03 | 56 | 194 | 3 | EFO_0006874 | |
| Disease | Alzheimer disease, educational attainment | 6.01e-03 | 247 | 194 | 6 | EFO_0011015, MONDO_0004975 | |
| Disease | triacylglycerol 56:3 measurement | 6.14e-03 | 18 | 194 | 2 | EFO_0010430 | |
| Disease | lysophosphatidylcholine 22:6 measurement | 6.14e-03 | 18 | 194 | 2 | EFO_0010365 | |
| Disease | spine bone size | 6.14e-03 | 18 | 194 | 2 | EFO_0004508 | |
| Disease | brain volume measurement | EPHB2 DLG2 ZNF282 MTCH2 PRKD2 FRAS1 ADAMTS8 ZIC1 RHPN2 SBNO1 | 6.25e-03 | 595 | 194 | 10 | EFO_0006930 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YSRQEGLDGGLPEEV | 761 | Q8N163 | |
| LFRGGDPSETLQGEL | 856 | Q6ZSZ5 | |
| FGFEGLLGAEDLSGV | 166 | Q96FF9 | |
| EIGFQGDDPKTDFRG | 161 | Q8N336 | |
| VGRADFLEQPVLGFV | 231 | P02730 | |
| DLERDGSVGIAGFVP | 101 | Q9UNA0 | |
| FLLDGEEFTIQPQGA | 126 | Q9UP79 | |
| GVPAEGAFTEDFQGL | 276 | P57764 | |
| GLNLDTDLFVGGVPE | 1486 | O00468 | |
| ELEGRRGIFPEGFVE | 186 | Q6XZF7 | |
| LLPFGDQTEIGERGI | 796 | O60706 | |
| FEGFLEGVGIREGGI | 481 | Q9NUG4 | |
| GFQEVPELVARFDGL | 156 | A6NFT4 | |
| VGTLFRFPGGVSGEE | 61 | Q9NRI5 | |
| EFGDAELIQTFLPFG | 406 | Q96J87 | |
| FGNIPGIDLAFIENG | 336 | Q7Z2K6 | |
| PQVGLFLDAVVFGGE | 191 | Q8N0X4 | |
| PGLGGGDFETFENLR | 1351 | Q9HC84 | |
| REEGILGFFAGLVPR | 171 | Q9Y6C9 | |
| ALARIFGGVEDGPEA | 106 | P55042 | |
| GHIREFPVFGEGEGV | 161 | Q9H790 | |
| GEGGEFSVDRPIIDR | 146 | Q8NC51 | |
| GRGDGQEAPDVVAFV | 11 | O60829 | |
| QEIEIGESGFALLFP | 166 | Q8NEZ5 | |
| GESGFALLFPQIEGI | 171 | Q8NEZ5 | |
| GEFGDEFVPRVAAFG | 26 | P13349 | |
| VLPFVRGVDLSGNDF | 6 | Q13045 | |
| GTNPFFIIEEGGKEI | 2406 | Q86XX4 | |
| GLSAPGRLFDQRFGE | 21 | O14558 | |
| PYDVEIRRGENEGFG | 996 | Q96QZ7 | |
| FGFTIIGGDEPDEFL | 436 | Q86UL8 | |
| GFTIIGGDRPDEFLQ | 421 | Q5TCQ9 | |
| FGFRVLGGDGPDQSI | 736 | Q5TCQ9 | |
| GFPGGFVDTQDRSLE | 56 | Q96DE0 | |
| LRVGFEAGGLEPQAF | 141 | A4FU01 | |
| EVLEFLGRGTFGQVA | 191 | Q86Z02 | |
| LGGRFVDFQPLGFGV | 16 | P31152 | |
| VDREYFGDIGLLDPG | 331 | Q9HCQ5 | |
| LQGGPEVAFRFGAVL | 56 | Q96FN5 | |
| FGAPVGGVLFSLEEG | 301 | P51798 | |
| KTDPGRGREIQGIFF | 1026 | P29323 | |
| GERNVLIFDLGGGTF | 191 | P0DMV9 | |
| VRAGGFEFSPGTLQV | 1221 | Q9UIW2 | |
| LVPALEAFGLEGVFR | 361 | Q6L8Q7 | |
| ETVGLSFGNIPVFGD | 81 | O15018 | |
| FDPLGIVDGFTAEVG | 891 | Q32MH5 | |
| GRFPVEIANEIDGTF | 416 | Q5GLZ8 | |
| PGLVETFGDLAFGDI | 446 | Q8WX92 | |
| PQGFGFLLREEKGLD | 336 | Q86UT5 | |
| PGFDGYIDLGRELSV | 561 | Q9UJF2 | |
| IFPDEVLGSGQFGVV | 551 | Q9BZL6 | |
| VDEPGVFIFNVLDGG | 401 | Q8TBB1 | |
| PFGSRGEFEGFVAVV | 321 | Q9NY33 | |
| FGGRVDAGQPELLTE | 21 | Q9UHN1 | |
| GFGEAAPRFRGQVLF | 296 | Q13087 | |
| TSENIGFFGGDPLRI | 281 | Q8N2Q7 | |
| VEGLSFPDAGFTGLI | 251 | Q9ULW8 | |
| FEVFQPGDLVVREGS | 446 | Q9P1Z3 | |
| FFIEVGRSAVTGPGE | 221 | P35568 | |
| QFLEGPEGIENTRFG | 541 | P17301 | |
| GADDGRFTLPGEIDI | 621 | A2RRP1 | |
| FQLIFEGIRGPGIEG | 891 | Q7Z553 | |
| FGGGDPADIIHDFQR | 136 | Q9NQX7 | |
| EQGVPKSGEGFIDFI | 1846 | Q13332 | |
| FADNSGIDIILGVFP | 621 | Q9NVE7 | |
| FSDFLDGLGPAQLVG | 1516 | Q86UR5 | |
| NPRGFFLFVEGGRID | 321 | P10696 | |
| SLGFDLDRGEVGTVP | 136 | Q9H237 | |
| EFGGRVGVFPSLLVE | 591 | Q86WN1 | |
| LFIFGRDEFPGQAVA | 421 | Q9HB29 | |
| RFFVLRGPGAGGDEA | 46 | Q9Y4H2 | |
| GKFLFEVVPGGDRDR | 81 | Q8N264 | |
| FEDLPGQLARIAGEA | 151 | Q9BU20 | |
| LNFRLLEGIDGFPES | 496 | Q9UFP1 | |
| GLEGKGFEPTLEALF | 691 | P04114 | |
| PLDIGGADQEFFVDI | 1346 | P08123 | |
| RFYEAGEELTGPGAV | 376 | Q9HAH7 | |
| NYGDLGFLGPEDLRV | 496 | Q9Y4L1 | |
| GFLGPEDLRVFGSQN | 501 | Q9Y4L1 | |
| RLSEEEFGGFRIGNG | 241 | Q6UX52 | |
| AFGPGTEGQVERFET | 876 | P40189 | |
| NNFVFLLGGEELGPD | 326 | Q96M94 | |
| GGRLLVFAPGREDEG | 376 | Q5SW24 | |
| DFARFDPQGGLAGIA | 76 | P06340 | |
| DGQVDFEEFVTLLGP | 86 | Q86V35 | |
| GPDGEQLFELVGERS | 1551 | P17927 | |
| FTFQVIIDGREFPEG | 41 | P19525 | |
| IPFGVIFGGTDVNED | 76 | Q96MS3 | |
| FQSILDTLGGPGERE | 311 | Q9BPX7 | |
| GGRQGDPQIFLGSDF | 76 | Q8WZB0 | |
| FNGDGIDDFVSGVPR | 261 | P06756 | |
| VFLLDGSEGVRSGFP | 1031 | P12111 | |
| EEILLRGFDVGFSGQ | 486 | Q6NUI2 | |
| EGAPERAAELGVNFG | 156 | P10075 | |
| FFPGLQVLIGDVEDA | 441 | Q92611 | |
| GAEYINPGERLIEEG | 1521 | Q99698 | |
| DVGSIPGRFSDNGFL | 831 | O00462 | |
| VFGERFGGGNPELLT | 606 | P40939 | |
| TPAEGDIGAVFGLGF | 696 | P40939 | |
| GPSDFFIGAVIEVFG | 486 | Q5JVL4 | |
| DGPGAEEDFLRQLGS | 71 | Q17RN3 | |
| DGPDRGYVFGLENLI | 416 | Q92551 | |
| GEPGDEFFIILEGSA | 286 | P10644 | |
| EGFLEAGSQGRFLVE | 436 | Q6UWL6 | |
| IDRDGNGTVDFPEFL | 56 | P27482 | |
| FEEITLERGNSGLGF | 96 | Q15700 | |
| GLEELLGIDPSFEQF | 51 | Q9H583 | |
| LIFRLEGVDGGQSPR | 6 | O00418 | |
| SAEEEGLRLFVGPGG | 321 | Q5T8I3 | |
| GERNVLIFDLGGGTF | 191 | P0DMV8 | |
| GEEFSGRGIFPLAER | 91 | P11712 | |
| LEGNALEELRPGTFG | 141 | Q6NUI6 | |
| IFFGVELLEEGRGQG | 161 | Q9NQC7 | |
| ARFGQGSGPIVLDDV | 416 | Q9UGM3 | |
| RFGQGSGPIVLDDVR | 656 | Q9UGM3 | |
| ARFGQGSGPIVLDDV | 786 | Q9UGM3 | |
| RFGQGSGPIVLDDVR | 916 | Q9UGM3 | |
| ARFGQGSGPIVLDDV | 1046 | Q9UGM3 | |
| RFGQGSGPIVLDDVR | 1176 | Q9UGM3 | |
| DGDFGQIVRYGEIPA | 226 | Q96RP9 | |
| ETFLPNGDRAGFLIG | 306 | A3KN83 | |
| TAFREIEIGDGFLPV | 1176 | P21817 | |
| RRGIGGIFFDDLDSP | 331 | P36551 | |
| LGLGSLGEERFPVVN | 31 | Q8NFZ4 | |
| LDGGDVLFTGREFFV | 126 | O94760 | |
| IRPGEFEQFESTIGF | 351 | Q9Y2J2 | |
| NRPGVLFFEGDEGLT | 436 | Q05469 | |
| VTEFGLIGIGDVNPF | 506 | Q8N344 | |
| DVDPVLAFQREGFGR | 811 | Q8TEW0 | |
| EGGVFDLGPFIVDLI | 316 | Q14653 | |
| GFGEGVSFRGRILVE | 386 | Q2WGJ9 | |
| FGRNSFLGEVEIPFD | 501 | Q8TDW5 | |
| LGDRGFFPDAAVFIQ | 1136 | Q5TCS8 | |
| FQDEGGQLLGSPFDV | 21 | Q9NVX2 | |
| FYEGELLDGQRGLVP | 211 | O15034 | |
| NDIVFDPFVGTGGLL | 216 | Q7Z4G4 | |
| QLPFRGDEGIFEESF | 101 | Q9UMY4 | |
| RGLYDFEPENQGELG | 291 | Q99963 | |
| VFFDIAVDGEPLGRV | 6 | P62937 | |
| AVDGEPLGRVSFELF | 11 | P62937 | |
| FRVESGALGPEENFL | 6 | Q9BRX5 | |
| GEDERVLFTFPGNLV | 161 | Q9Y4C2 | |
| DIGINQGFGDSFGRL | 421 | Q9P2K5 | |
| EEEINLTRGPSGLGF | 11 | P57105 | |
| GISEEPELQAFLFGL | 16 | O76100 | |
| LASFFGELLGQEIDP | 76 | Q16773 | |
| PRVFFDVDIGGERVG | 16 | Q08752 | |
| GPAFEEFLDLLGQRV | 631 | Q9P2F8 | |
| ISGTPVQRGLEDLFG | 846 | Q149N8 | |
| PRDGQGRLGFEVDAE | 691 | Q96FS4 | |
| GDPGTIFFFREGAAV | 221 | Q9NWS8 | |
| FRGGDLIEILGAQVP | 326 | Q8TE82 | |
| PNLGLELFEAAGDIF | 1106 | Q8TE82 | |
| GAFFGEGSGPIILDD | 356 | A1L4H1 | |
| PTGLDFGQEGFTRFR | 541 | P46087 | |
| LFGGGAQSLDREELF | 1051 | Q5T5C0 | |
| AEEGDLGFTLRGNAP | 521 | Q8IUC4 | |
| GVFINTGPEFLVGCD | 716 | Q15047 | |
| GQLLSFDIGDQPVFE | 116 | Q08945 | |
| FFDGVRVPSENVLGE | 311 | P49748 | |
| RVPSENVLGEVGSGF | 316 | P49748 | |
| PIEGEGNIARFLFSL | 206 | Q13155 | |
| PLGDRIINAFFPEGE | 61 | Q99653 | |
| GLREGFSGDPVTLQE | 6 | P51800 | |
| GETLSFIFPEGIVAG | 441 | P51801 | |
| PVFVIGAAFGRLVGE | 461 | P51788 | |
| FGAPIGGVLFSLEEV | 326 | P51790 | |
| IEGLQDSFPARFGGV | 206 | Q8IUQ0 | |
| PVGLFELFFDEGTIN | 141 | Q6P3X8 | |
| QELQSLGFGPEEGSL | 581 | Q96EP0 | |
| LGFGPEEGSLQALFQ | 586 | Q96EP0 | |
| GGGGDDFFLVLLDPV | 86 | P98169 | |
| LGNPFGLIREFSEGV | 2866 | Q96RL7 | |
| LDLFGERRGLFGVPE | 56 | Q99797 | |
| RKVTFFEPGSGDENG | 381 | O95793 | |
| VGGGFAGLEFARPQE | 46 | Q9NR83 | |
| GEPSEVFINRDRGFG | 106 | Q8WXF1 | |
| VFRPGDVFFNTGDLL | 516 | Q5K4L6 | |
| GVDSGFEAPRLGEQG | 346 | A1L020 | |
| FLPEEATEEAGVRGG | 1006 | Q9H7N4 | |
| LGEVEDARGFTPVAF | 126 | Q6NTF9 | |
| GQDVAFSRSFLPGEG | 691 | A1X283 | |
| AFFSPFRIVNEGGID | 1101 | Q92626 | |
| AIRQGPEGLEVSFRG | 51 | Q8TDP1 | |
| GPEEFAEGLVIGVRS | 3451 | Q709C8 | |
| QLPFAEGAGDGARLD | 246 | Q6ZSY5 | |
| PDSADGLGFQIRGFG | 681 | Q70Z35 | |
| DFGLDVPAFRTLVGD | 266 | Q15569 | |
| GDLGFTLRGNAPVEV | 421 | A8MT19 | |
| RRAFEETQIDIPGGG | 3701 | Q15149 | |
| DPDLGGSQFGRIIFV | 196 | Q6ZUG5 | |
| GDVAERDVGLGINPF | 26 | Q15915 | |
| AGELVFRPRDGAEGQ | 771 | Q13105 | |
| PFRDEGFDAIISIGV | 96 | Q9P272 | |
| PDRFVVLETGGEAGI | 46 | Q7Z2W4 | |
| GGRVGFDPFLLSIDT | 151 | O43895 | |
| GLPEGFQLLQIDAEG | 31 | Q6PF06 | |
| GFPPRVERLEEFEGG | 11 | Q96S53 | |
| EIGSGLLREKDFFPG | 356 | Q2TAA8 | |
| IRNLYLDFGGPEGEL | 496 | Q13425 | |
| FFIGDSGIPLEVIAG | 81 | Q92575 | |
| EDLRDGGVPFFVNRG | 51 | Q7L8A9 | |
| PFGISALIVGFDFDG | 126 | O14818 | |
| GEEIEGRLQEGTFPG | 671 | Q7Z4V0 | |
| GLLDDGFQVLPGERG | 446 | Q9UDV7 | |
| DNEFFGDPIEVVGQR | 516 | Q15386 | |
| GIDGGGIFREFLNEL | 766 | Q15386 | |
| EFDSFLPGAIIGIAR | 241 | Q8NBI6 | |
| GPFSGFGEVLFRESV | 526 | Q9H7M6 | |
| LQDFLGFGVLGPEGQ | 196 | Q8WU03 | |
| NGRVDGFGLLTFPDG | 91 | Q8NDC4 | |
| GEFLPLDQLELDVGF | 241 | P48549 | |
| QLGRIAPGAFDDFLE | 131 | Q6PJG9 | |
| IGEGAFGRVFQARAP | 581 | O15146 | |
| FQLNELFGPVGIDSG | 1386 | Q86UW6 | |
| TGFADLGFDVDIGPL | 636 | P22033 | |
| EFLFEVGVSNVFGPG | 711 | P22033 | |
| GGSTRLFILQGPEED | 266 | Q9BWU0 |